Preparations continue for rollout of new public health surveillance platform in nine pilot countries
Next year’s rollout of Epi+, a multilingual event-based surveillance platform designed to help countries detect and assess emerging public health threats, is coming closer as ECDC and Italy’s Istituto Superiore di Sanità (ISS) hold training this week for 40 national epidemiologists and technical experts in Rome.
A surveillance tool that interacts with the latest available data on infectious diseases and allows users to produce tables and maps.
This social media card explains that approx. 60% of infant hospitalisations from RSV could be prevented through immunising 90% of newborns.
In the EU/EEA, respiratory illness activity remains at baseline or low levels. SARS-CoV-2 is the main contributor, and its circulation continues to increase in several countries. Influenza activity remains low but increases in several countries. RSV activity remains very low.
This report was produced by the European Centre for Disease Prevention and Control on behalf of the European Respiratory Virus Network (ERVI-Net) and its subnetwork the European Reference Laboratory Network for Human
Influenza (ERLI-Net).
Influenza virus characteristics, week 40 2025 to week 33 2026, EU/EEA
English (3.59 MB - PDF)
ESCAIDE is Europe’s leading public health conference dedicated to sharing knowledge on infectious disease epidemiology, public health microbiology, and related scientific fields.
General disease information for public health experts.
In this video, representatives of the EURLs explain how they work together to strengthen laboratory capacity across Europe through quality assessments, specialist training, shared testing methods and expertise. Hear directly from the experts about their work, the importance of collaboration and how the network helps countries prepare for and respond to infectious disease threats.
Strong laboratory capacity is the backbone of Europe’s preparedness in the face of increasing communicable disease threats, said ECDC on the occasion of today’s European Laboratory Day, celebrated every year on 5 November to recognise the essential contribution of laboratory professionals across Europe.
This document provides an overview of the newly established EU Reference Laboratories for Public Health (EURLs), their core tasks and services, and the stakeholders involved, with the aim of supporting Member State laboratories in accessing and benefiting from the services available.
A guide to EU Reference Laboratories for Public Health
English (391.59 KB - PDF)
In this video, representatives from ECDC, the European Commission's Directorate-General for Health and Food Safety (DG SANTE), the European Health and Digital Executive Agency (HaDEA) and the World Health Organization Regional Office for Europe (WHO/Europe) explain how the EU Referenece Laboratories for Public Health work and why cooperation matters.
Watch the presentation of the EU Reference Laboratories for Public Health recorded at ESCAIDE 2025 in Warsaw.
ECDC principles on transparency, independence and open access.
This editorial guidance on inclusive writing at ECDC provides people with an understanding of how language can contribute to stigma and uncertainty in public health.
Inclusive writing at ECDC
English (3.04 MB - PDF)
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
View surveillance data in dashboards and reports for seasonal influenza.
Guidance and protocols to support seasonal influenza surveillance.
The Management Board approves and monitors the implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.
In the EU/EEA, respiratory illness activity remains at baseline or low levels. SARS-CoV-2 circulation continues to increase in several countries. Influenza and RSV activities remain low.
This report provides an overview of measles and rubella cases reported to ECDC through The European Surveillance System (TESSy).
This report provides an overview of measles and rubella cases reported to ECDC through The European Surveillance System (TESSy).
The first cycle of Public Health Emergency Preparedness Assessments (PHEPAs) coordinated by the European Centre for Disease Prevention and Control (ECDC) has shown a strong commitment to emergency preparedness across Europe, with a number of common challenges remaining.
Respiratory Syncytial Virus (RSV) is a major cause of respiratory infections across the EU/EEA, representing a recurrent source of pressure on healthcare systems. The burden of disease is particularly high in older adults, people with underlying comorbidities, and young children, resulting in increased demand for hospital care, especially for paediatric admissions.
Multi-model assessment of the impact of newborn RSV immunisation on hospitalisation burden in the EU/EEA
English (979.8 KB - PDF)
As the season for respiratory syncytial virus (RSV) and other respiratory diseases approaches, a new report from the European Centre for Disease Prevention and Control (ECDC) indicates that universal immunisation of newborns against RSV could substantially reduce hospitalisations among infants linked to the disease during the winter season.